Mani (TSE:7730) Cyclically Adjusted Revenue per Share: 円237.62 (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:7730 Mani Inc TSE:7730
93 GF Score
Price 円1,514.00
GF Value 円2,140.68
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Mani Cyclically Adjusted Revenue per Share?

Mani TSE:7730 -2.39% 93 Cyclically Adjusted Revenue per Share is 円237.62 as of Feb. 2026. GuruFocus rates TSE:7730 with a GF Score™ of 93/100 and a GF Value™ of 円2,140.68 (Modestly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Mani's adjusted revenue per share for the three months ended in Feb. 2026 was 円84.039. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円237.62 for the trailing ten years ended in Feb. 2026.

During the past 12 months, Mani's average Cyclically Adjusted Revenue Growth Rate was 7.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Mani was 11.30% per year. The lowest was 4.90% per year. And the median was 9.00% per year.

As of today (2026-07-29), Mani's current stock price is 円1514.00. Mani's Cyclically Adjusted Revenue per Share for the quarter that ended in Feb. 2026 was 円237.62. Mani's Cyclically Adjusted PS Ratio of today is 6.37.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Mani was 22.16. The lowest was 4.87. And the median was 10.75.


Mani  (TSE:7730) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Mani's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1514.00/237.62
=6.37

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Mani was 22.16. The lowest was 4.87. And the median was 10.75.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Mani Cyclically Adjusted Revenue per Share Related Terms


Mani Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Mani's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mani Cyclically Adjusted Revenue per Share Chart

Mani Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 152.21 167.58 187.61 209.61 230.15

Mani Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 226.74 230.15 235.71 237.62 0.00

TSE:7730 vs ISRG, BDX, MDLN: Cyclically Adjusted Revenue per Share Comparison

For the Medical Instruments & Supplies subindustry, Mani's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mani Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Mani's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Mani's Cyclically Adjusted PS Ratio falls into.


TSE:7730
93GF Score
Mani Inc TSE:7730
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mani Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Mani's adjusted Revenue per Share data for the three months ended in Feb. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Feb. 2026 (Change)*Current CPI (Feb. 2026)
=84.039/112.2000*112.2000
=84.039

Current CPI (Feb. 2026) = 112.2000.

Mani Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201605 43.431 98.200 49.623
201608 44.929 97.900 51.492
201611 41.006 98.600 46.662
201702 42.359 98.100 48.447
201705 42.543 98.600 48.411
201708 48.511 98.500 55.258
201711 47.836 99.100 54.159
201802 50.343 99.500 56.769
201805 53.877 99.300 60.876
201808 52.185 99.800 58.669
201811 48.781 100.000 54.732
201902 43.560 99.700 49.021
201905 47.651 100.000 53.464
201908 46.210 100.000 51.848
201911 44.145 100.500 49.284
202002 41.960 100.300 46.938
202005 34.421 100.100 38.582
202008 33.903 100.100 38.001
202011 42.661 99.500 48.106
202102 41.706 99.800 46.888
202105 47.050 99.400 53.109
202108 43.218 99.700 48.637
202111 48.036 100.100 53.843
202202 50.017 100.700 55.729
202205 52.618 101.800 57.994
202208 56.753 102.700 62.003
202211 62.026 103.900 66.981
202302 60.108 104.000 64.847
202305 65.955 105.100 70.411
202308 60.581 105.900 64.185
202311 72.226 106.900 75.807
202402 68.977 106.900 72.397
202405 78.130 108.100 81.093
202408 70.068 109.100 72.059
202411 77.747 110.000 79.302
202502 72.642 110.800 73.560
202505 75.841 111.800 76.112
202508 78.051 112.100 78.121
202511 79.477 113.200 78.775
202602 84.039 112.200 84.039

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of 円237.62 mean?
Mani (TSE:7730) has a Cyclically Adjusted Revenue per Share of 円237.62 as of Feb. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Mani and its competitors.
Is Mani's Cyclically Adjusted Revenue per Share too high?
Mani's current Cyclically Adjusted Revenue per Share is 円237.62. Overall, Mani has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mani's Cyclically Adjusted Revenue per Share compare to ISRG and BDX?
Mani's Cyclically Adjusted Revenue per Share of 円237.62 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Mani and its competitors. Mani's current Cyclically Adjusted Revenue per Share is 円237.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mani stock overvalued right now?
Based on GuruFocus' analysis, Mani (TSE:7730) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,140.68, compared to a current price of 円1,514.00 — trading 29.3% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is 円237.62. Mani's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Mani (TSE:7730), the current Cyclically Adjusted Revenue per Share is 円237.62 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mani (TSE:7730) Overvalued in 2026?

Based on GuruFocus' analysis, Mani stock appears to be undervalued. The current stock price of 円1,514.00 is trading 29.3% below its estimated GF Value™ of 円2,140.68. GuruFocus considers Mani to be Modestly Undervalued.

Key valuation signals for TSE:7730:

  • Cyclically Adjusted Revenue per Share: 円237.62
  • GF Value™: 円2,140.68 vs. price of 円1,514.00 (29.3% below fair value)
  • GF Score™: 93/100 with 2 warning signs

No single metric tells the full story. See the TSE:7730 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mani Business Description

Address 8-3 Kogyodanchi, Tochigi, JPN
Mani Inc manufactures medical devices and dental instruments. It sells products in four categories: surgical instruments, ophthalmic instruments, suture needles, and dental instruments. Mani's surgical products include instruments such as staplers, vessel knives, and bone saws. Its ophthalmic instruments include a range of knives used during eye surgery and ophthalmic sutures. Mani's suture needles business includes a variety of taper point and cutting eyeless needles, which require suture attachment and sterilization by the customer, as well as stainless-steel eyed needles. The firm's dental instruments include endodontic instruments and accessories, root canal equipment, and finishing and polishing instruments.
93GF Score

Get the complete analysis for TSE:7730

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,514.00
Price
円2,140.68
GF Value